首页 › 套细胞淋巴瘤 › 密苏里州 › St. Louis
St. Louis MO 套细胞淋巴瘤临床试验
8项针对 套细胞淋巴瘤的研究正在 St. Louis及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
招募中3 期
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- 以及另外 4 项
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
招募中1/2 期
- Washington University School of Medicine, St Louis
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
招募中3 期
- Washington University School of Medicine, St Louis
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
招募中1 期
- Washington University School of Medicine, St Louis
DALY II USA/ MB-CART2019.1 for DLBCL
招募中2 期
- Washington University, St. Louis, St Louis
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
招募中2 期
- Washington University, St Louis
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
招募中1/2 期
- Washington University, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, St Louis
其他城市的 套细胞淋巴瘤试验
- Houston, TX15 项研究
- Baldwin Park, CA15 项研究
- Durham, NC13 项研究
- New York City, NY12 项研究
- Seattle, WA12 项研究
- Milwaukee, WI12 项研究
- Boston, MA11 项研究
- Nashville, TN11 项研究
- Columbus, OH11 项研究
- Chicago, IL10 项研究
- Rochester, MN9 项研究
- Portland, OR9 项研究
St. Louis的其他研究
- 非小细胞肺癌73 项研究
- 乳腺癌64 项研究
- 转移性癌症54 项研究
- 结直肠癌50 项研究
- 癌症（所有类型）46 项研究
- 前列腺癌46 项研究
- 肺癌39 项研究
- 卵巢癌38 项研究
- 胰腺癌33 项研究
- 子宫内膜癌29 项研究
- 头颈鳞状细胞癌28 项研究
- 心力衰竭26 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。